Segment and Geographic Information

3 Months Ended

Mar. 31, 2012

Segment and Geographic Information

14.          Segment and Geographic Information

The Company has one reportable operating segment, the results of which are disclosed in the accompanying unaudited condensed consolidated financial statements.

Product revenue by product group is as follows:

	Three Months Ended March 31,
	2012		2011
Orthobiologics	$	10,116,845	$	8,036,298
Dermal		501,315		589,153
Ophthalmic		1,323,994		897,808
Surgical		983,628		1,113,728
Veterinary		687,546		423,172
	$	13,613,328	$	11,060,159

Product revenue by geographic location in total and as a percentage of total product revenue, for the three months ended March 31, 2012 and 2011 are as follows:

	Three Months Ended March 31,
	2012					2011
			Percentage of					Percentage of
Geographic Location:	Revenue		Revenue			Revenue		Revenue
United States	$	10,390,045		76	%	$	8,343,114		76	%
Europe		2,155,729		16	%		2,033,198		18	%
Other		1,067,554		8	%		683,847		6	%
Total	$	13,613,328		100	%	$	11,060,159		100	%